Financial Statements — RCT
Balance Sheet
(in millions USD)| Metric | Q2
2025 |
|---|
| Cash & Equivalents | 0.87 |
| Accounts Receivable | 2.49 |
| Total Current Assets | 5.76 |
| Property, Plant & Equipment | 0.57 |
| Intangible Assets | 7.07 |
| Total Non-current Assets | 7.65 |
| Total Assets | 13.40 |
| Accounts Payable | 4.23 |
| Short-term Debt | 0.32 |
| Total Current Liabilities | 21.41 |
| Total Non-current Liabilities | 22.56 |
| Total Liabilities | 21.41 |
| Retained Earnings | (174.97) |
| Total Stockholder Equity | (8.00) |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 |
|---|
| Total Revenue | 17.97 |
| Selling, General & Admin | 1.35 |
| Total Operating Expenses | 37.97 |
| Operating Income | (20.00) |
| Pretax Income | (27.03) |
| Tax Provision | (0.49) |
| Net Income | (26.54) |
| Basic EPS | (0.74) |
| Diluted EPS | (0.74) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 |
|---|
| Operating Cash Flow | (15.92) |
| Capital Expenditures | 0.13 |
| Free Cash Flow* | (16.04) |
| Investing Cash Flow | (2.23) |
| Financing Cash Flow | 20.73 |
* Derived from reported values